Jade Biosciences, Inc. JBIO
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-30
Jade Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 929,407 | $20.7M | 1.88% |
| MILLENNIUM MANAGEMENT LLC | 314,548 | $7.0M | 0.64% |
| Point72 Asset Management, L.P. | 167,204 | $3.7M | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 73,591 | $1.6M | 0.15% |
| D. E. Shaw & Co., Inc. | 51,494 | $1.1M | 0.1% |
| TWO SIGMA INVESTMENTS, LP | 45,361 | $1.0M | 0.09% |
| AQR CAPITAL MANAGEMENT LLC | 13,311 | $295,769 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.